SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 132 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$3,000
+50.0%
199
+17.1%
0.00%0.0%
Q4 2018$2,000
-50.0%
170
-11.0%
0.00%0.0%
Q3 2018$4,000
+33.3%
191
+7.9%
0.00%0.0%
Q2 2018$3,0001770.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Fosun International Ltd 19,552,001$433,859,00020.80%
BRIDGER MANAGEMENT, LLC 2,642,621$58,640,0003.39%
TPG Group Holdings (SBS) Advisors, Inc. 3,884,600$86,199,0001.10%
HUSSMAN STRATEGIC ADVISORS, INC. 125,000$2,774,0000.80%
HealthCor Management, L.P. 1,036,110$22,991,0000.76%
GW&K Investment Management, LLC 2,049,765$45,484,0000.73%
Bridge City Capital, LLC 50,434$1,119,0000.70%
TCW GROUP INC 2,521,064$55,942,0000.46%
FRONTIER CAPITAL MANAGEMENT CO LLC 2,876,367$63,827,0000.41%
Quadrant Capital Management, LLC 25,002$555,0000.35%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders